Cyclooxygenase inhibitors enhance the production of tissue inhibitor-1 of metalloproteinases (TIMP-1) and pro-matrix metalloproteinase 1 (proMMP-1) in human rheumatoid synovial fibroblasts

Inflammation Research

Volumn 46, Issue 8, 1997, Pages 320-323

  Takahashi, S ^a,b   Inoue, T ^a   Higaki, M ^a   Mizushima, Y ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Diclofenac; Indomethacin; MMP 1; TIMP 1

Indexed keywords

COLLAGENASE; DICLOFENAC; INDOMETACIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT INTERLEUKIN 1BETA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; COLLAGENASES; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DINOPROSTONE; ENZYME PRECURSORS; FIBROBLASTS; HUMANS; INDOMETHACIN; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; RECOMBINANT PROTEINS; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0030815631     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050194     Document Type: Article

References (24)

1. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-63.
2. Nagase H, Enghild JJ, Suzuki K, Salvesen G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 1990;29:5783-9.
3. Windsor LJ, Birkedal-Hansen H, Birkedal-Hansen B, Engler JA. An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase. Biochemistry 1991;30:641-7.
4. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318:66-9.
5. Boone TC, Johnson MJ, De Clerck YA, Langley KE. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 1990;87:2800-4.
6. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992;267:17321-6.
7. Ward RV, Hembry RM, Reynolds JJ. Murphy G. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J 1991;278:179-87.
8. Cawston TE, Galloway WA, Mercer E, Murphy G, Reynolds JJ. Purification of rabbit bone inhibitor of collagenase. Biochem J 1981;195:159-65.
9. Stricklin GP, Welgus HG. Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem 1983;258:12252-8.
10. Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, Stricklin GP. Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res 1985;5:167-79.
11. Herron OS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activites is regulated by endogenous inhibitors. J Biol Chem 1986;261:2814-8.
12. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JR Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
13. Ito A, Nose T, Takahashi S, Mori Y. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes. FEBS Lett 1995;360:75-9.
14. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem 1992;267:515-9.
15. Takahashi S, Sato T, Ito A, Ojima Y, Hosono T, Nagase H, et al. Involvement of protein kinase C in the interleukin 1 alpha-induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts. Biochim Biophys Acta 1993;1220:57-65.
16. Takahashi S, Ito A, Nagino M, Mori Y, Xie B, Nagase H. Cyclic adenosine 3×,5×-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts. J Biol Chem 1991;266:19894-9.
17. Mitchell JA, Akarasereenout P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-7.
18. Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 1993;36:1444-50.
19. Krane SM, Conca W, Stephenson ML, Amento EP, Goldring MB. Mechanisms of matrix degradation in rheumatoid arthritis. Ann NY Acad Sci 1990;580:340-54.
20. Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawelee G. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characterisitics of synovial tissue. Ann Rheum Dis 1992;51:731-4.
21. Dromgoole SH, Furst DE, Desiraju RK, Nayak RK, Kirschenbaum MA. Tolmetin kinetics and synovial fluid prostaglandin E level in rheumatoid arthritis. Clin Pharmacol Ther 1982;32:371-7.
22. Netter P, Bannwarth B, Royer-Morrot MJ. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1989;17:145-62.
23. 2 synthesis. J Invest Dermatol 1995;104:52-7.
24. 2: selective enhancement of collagenase gene expression in human dermal fibroblasts in culture. J Cell Biochem 1994;54:465-72.